Efficacy and safety of Ruyi Zhenbao tablet in patients with lumbar disc herniation:A protocol for a multicenter,randomized,positive-controlled trial
摘要Objective:To evaluate the efficacy and safety of Ruyi Zhenbao tablet(RYZBT),a traditional Tibetan medicinal formula,for the treatment of lumbar disc herniation(LDH),that is frequently associated with lower back pain(LBP),through rigorous randomized controlled trials(RCTs).Methods:This multicenter,randomized,positive-controlled trial study will include 400 participants diagnosed with LDH,and include an enrollment period,a 4-week treatment period,and a 4-week follow-up period.Participants will be randomly assigned at a 1︰1 ratio for treatment with either RYZBT or diclofenac sodium sustained-release tablet(DSSRT)for 4 weeks.The time points of visits are set at baseline,during treatment(weeks 1,2,and 4),and during follow-up(weeks 2 and 4 post-treatment).The relevant outcome will be recorded at each timepoint.The primary outcomes include the Visual Analog Scale(VAS)scores for LBP and leg pain,as well as the Japanese Orthopaedic Asso-ciation scores for functional assessment.Secondary outcomes comprise the VAS scores for numbness,Oswestry Disability Index,rescue treatments,patient health education,and safety assessments.Discussion:This study has been designed to provide robust and reliable evidence of the efficacy and safety of RYZBT in alleviating LDH symptoms,with the goal of supporting evidence-based clinical ap-plications.By using DSSRT as a positive control,the placebo effect will be effectively minimized,enabling a more accurate assessment of RYZBT efficacy.
更多相关知识
- 浏览2
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



